YearStart,YearEnd,LocationAbbr,LocationDesc,DataSource,Topic,Question,Response,DataValueUnit,DataValueType,DataValue,DataValueAlt,DataValueFootnoteSymbol,DatavalueFootnote,LowConfidenceLimit,HighConfidenceLimit,StratificationCategory1,Stratification1,StratificationCategory2,Stratification2,StratificationCategory3,Stratification3,GeoLocation,ResponseID,LocationID,TopicID,QuestionID,DataValueTypeID,StratificationCategoryID1,StratificationID1,StratificationCategoryID2,StratificationID2,StratificationCategoryID3,StratificationID3
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.4,48.4,,,41.3,55.6,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.5,31.5,,,24.3,39.7,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,23.9,43.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.6,37.6,,,31.5,44.2,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.6,45.6,,,37.5,54.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.2,34.2,,,25.5,44.1,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.1,29.1,,,18.1,43.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.3,38.3,,,24.1,54.8,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,17.5,17.5,,,9.7,29.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.9,26.9,,,15.3,42.9,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.2,35.2,,,27.5,43.7,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.5,25.5,,,19.1,33.0,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,19.7,19.7,,,10.6,33.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,25.6,25.6,,,14.1,41.8,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.7,35.7,,,26.2,46.4,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.0,26.0,,,20.2,32.8,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.2,33.2,,,24.7,43.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.1,30.1,,,21.4,40.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.8,37.8,,,29.6,46.8,Overall,Overall,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.6,37.6,,,28.0,48.4,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.6,29.6,,,22.1,38.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.8,28.8,,,21.6,37.3,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.1,34.1,,,22.1,48.5,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.9,27.9,,,21.6,35.3,Overall,Overall,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.6,31.6,,,23.3,41.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.9,32.9,,,25.5,41.3,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,24.6,24.6,,,16.1,35.6,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.5,28.5,,,18.7,41.0,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.1,29.1,,,21.7,37.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.7,36.7,,,26.9,47.6,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.5,38.5,,,28.9,49.0,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.8,33.8,,,26.4,42.1,Overall,Overall,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.3,38.3,,,31.8,45.2,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.1,35.1,,,30.2,40.4,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.7,34.7,,,29.7,40.1,Overall,Overall,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,30.4,43.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.3,30.3,,,22.6,39.3,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.8,38.8,,,32.8,45.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.9,33.9,,,23.5,46.2,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.9,33.9,,,23.1,46.7,Race/Ethnicity,Hispanic,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.8,29.8,,,22.4,38.4,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.3,31.3,,,23.8,39.9,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.2,39.2,,,29.6,49.6,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,30.1,42.2,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.0,34.0,,,25.4,43.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.1,38.1,,,30.4,46.4,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.7,34.7,,,29.0,41.0,Overall,Overall,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.7,37.7,,,27.9,48.6,Race/Ethnicity,Hispanic,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,28.9,45.1,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.1,36.1,,,27.4,45.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.6,32.6,,,24.3,42.2,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.2,43.2,,,33.1,53.8,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.9,39.9,,,35.5,44.4,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.3,43.3,,,37.7,49.0,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.4,42.4,,,36.7,48.3,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.3,42.3,,,32.3,53.1,Race/Ethnicity,Hispanic,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.4,38.4,,,33.2,43.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.9,38.9,,,34.4,43.6,Overall,Overall,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.8,32.8,,,26.2,40.1,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,31.3,42.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.4,31.4,,,25.1,38.6,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.3,28.3,,,15.9,45.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.7,30.7,,,24.5,37.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.8,30.8,,,25.9,36.2,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.4,31.4,,,25.1,38.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,23.8,23.8,,,16.0,34.0,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.2,30.2,,,25.2,35.7,Overall,Overall,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,25.7,25.7,,,18.1,35.2,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,24.3,24.3,,,15.8,35.5,Race/Ethnicity,Hispanic,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.6,33.6,,,27.0,41.0,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.0,25.0,,,18.0,33.5,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,24.3,24.3,,,14.0,38.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.6,33.6,,,27.5,40.2,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,16.3,16.3,,,9.1,27.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,24.2,24.2,,,18.8,30.6,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.4,26.4,,,19.8,34.3,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,24.2,24.2,,,17.2,32.8,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.7,28.7,,,19.8,39.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,20.6,20.6,,,12.1,32.8,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,23.1,23.1,,,17.4,30.0,Overall,Overall,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.1,26.1,,,18.7,35.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,16.9,16.9,,,10.0,27.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,20.9,20.9,,,12.0,33.8,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.2,28.2,,,18.7,40.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.2,30.2,,,22.6,39.1,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.2,31.2,,,17.0,50.2,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.1,41.1,,,26.0,58.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.1,26.1,,,18.0,36.4,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.5,28.5,,,20.9,37.7,Overall,Overall,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.7,40.7,,,24.8,58.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.0,32.0,,,19.4,47.9,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.7,29.7,,,21.6,39.3,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.9,25.9,,,16.3,38.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Overall,Overall,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.7,34.7,,,29.3,40.6,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.4,27.4,,,17.8,39.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.6,28.6,,,18.7,41.2,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.9,37.9,,,30.8,45.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.4,32.4,,,22.9,43.7,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.2,38.2,,,30.4,46.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.6,36.6,,,29.2,44.6,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.0,29.0,,,20.9,38.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.2,34.2,,,28.0,40.9,Overall,Overall,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.3,35.3,,,29.0,42.1,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,25.0,25.0,,,15.6,37.6,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,21.3,21.3,,,12.3,34.3,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.0,28.0,,,20.9,36.4,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,24.2,24.2,,,15.4,35.8,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.6,31.6,,,22.5,42.4,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.8,27.8,,,18.3,39.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.0,29.0,,,23.0,35.8,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,21.2,21.2,,,12.1,34.6,Race/Ethnicity,Hispanic,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.9,32.9,,,20.0,49.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.9,30.9,,,20.8,43.1,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.8,32.8,,,21.8,46.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.2,27.2,,,20.5,35.1,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.2,28.2,,,22.7,34.5,Overall,Overall,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.0,29.0,,,21.4,38.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.7,44.7,,,39.1,50.4,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.3,45.3,,,39.1,51.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.5,46.5,,,40.4,52.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.0,48.0,,,40.8,55.3,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.2,46.2,,,40.5,51.9,Overall,Overall,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.6,40.6,,,32.6,49.2,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.7,42.7,,,33.9,51.9,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.3,46.3,,,38.9,53.8,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,23.9,23.9,,,16.3,33.5,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.8,33.8,,,27.8,40.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.9,31.9,,,25.9,38.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,24.8,24.8,,,16.9,34.9,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.9,35.9,,,28.8,43.7,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.3,33.3,,,27.8,39.4,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.7,31.7,,,26.3,37.8,Overall,Overall,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.8,37.8,,,30.8,45.3,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.5,26.5,,,16.1,40.5,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.0,43.0,,,30.9,56.0,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.3,38.3,,,28.9,48.7,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.0,36.0,,,25.4,48.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.8,38.8,,,29.5,49.0,Overall,Overall,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.1,36.1,,,25.4,48.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.8,41.8,,,30.8,53.8,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.4,28.4,,,16.6,44.3,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.4,39.4,,,33.8,45.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.8,34.8,,,29.7,40.3,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.5,35.5,,,30.9,40.4,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.7,35.7,,,27.5,44.7,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.1,34.1,,,29.5,39.1,Overall,Overall,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,22.3,22.3,,,13.4,34.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,21.2,21.2,,,13.2,32.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.9,36.9,,,28.0,46.9,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.3,37.3,,,31.4,43.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.8,32.8,,,27.7,38.2,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.4,32.4,,,26.9,38.4,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.5,42.5,,,38.5,46.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,21.6,48.5,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.2,41.2,,,37.0,45.5,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.5,40.5,,,37.0,44.2,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.3,38.3,,,34.9,41.8,Overall,Overall,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.5,44.5,,,40.0,49.0,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.4,33.4,,,27.8,39.5,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.8,38.8,,,35.1,42.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.6,37.6,,,24.6,52.6,Race/Ethnicity,Hispanic,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.0,34.0,,,26.9,41.8,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,26.9,47.5,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.0,34.0,,,27.5,41.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.6,39.6,,,29.2,51.0,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.1,37.1,,,30.7,44.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.8,32.8,,,27.0,39.2,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.5,31.5,,,24.6,39.4,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.8,35.8,,,29.8,42.3,Overall,Overall,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.0,43.0,,,34.2,52.2,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.1,35.1,,,26.4,44.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.2,34.2,,,27.6,41.5,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.2,40.2,,,31.5,49.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.2,27.2,,,19.3,36.9,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.8,38.8,,,30.8,47.4,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.7,31.7,,,25.6,38.4,Overall,Overall,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.6,27.6,,,17.6,40.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,16.1,16.1,,,8.8,27.4,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.7,33.7,,,26.9,41.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.8,38.8,,,32.5,45.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.9,29.9,,,22.5,38.4,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.9,34.9,,,28.2,42.2,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.5,33.5,,,28.2,39.2,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,28.8,37.6,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.0,33.0,,,27.7,38.7,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.1,32.1,,,27.7,36.8,Overall,Overall,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.3,35.3,,,28.7,42.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.7,37.7,,,33.9,41.8,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.3,29.3,,,21.6,38.4,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.6,35.6,,,29.4,42.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.9,32.9,,,27.6,38.7,Overall,Overall,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.0,27.0,,,17.3,39.6,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.1,29.1,,,17.4,44.3,Race/Ethnicity,Hispanic,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.3,34.3,,,29.2,39.8,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.8,32.8,,,25.7,40.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.7,37.7,,,30.5,45.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.2,30.2,,,22.6,39.0,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.5,34.5,,,27.8,41.7,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.7,28.7,,,21.7,36.8,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.8,38.8,,,33.7,44.2,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.5,38.5,,,32.9,44.3,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.6,43.6,,,37.8,49.5,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.5,42.5,,,37.5,47.6,Overall,Overall,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.2,38.2,,,28.7,48.7,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.4,42.4,,,37.4,47.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.3,40.3,,,31.2,50.1,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.5,37.5,,,32.6,42.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.8,39.8,,,31.4,48.8,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.3,42.3,,,36.6,48.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.2,33.2,,,23.0,45.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.0,40.0,,,31.9,48.6,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.2,41.2,,,35.6,47.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.1,41.1,,,36.2,46.1,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.8,41.8,,,36.0,47.9,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.4,28.4,,,19.0,40.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.8,39.8,,,34.9,44.9,Overall,Overall,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.3,39.3,,,33.4,45.6,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.7,38.7,,,34.9,42.7,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.1,40.1,,,35.4,45.0,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.8,37.8,,,34.0,41.8,Overall,Overall,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.6,38.6,,,34.2,43.3,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,29.4,42.9,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.3,40.3,,,36.1,44.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.1,39.1,,,34.6,43.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.3,36.3,,,29.9,43.3,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.2,42.2,,,35.6,49.1,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.1,35.1,,,22.2,50.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.6,35.6,,,27.5,44.6,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.3,39.3,,,24.8,56.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.8,36.8,,,28.4,46.2,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.4,39.4,,,33.5,45.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.3,40.3,,,35.0,45.8,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.3,40.3,,,34.0,47.0,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.6,41.6,,,35.6,48.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.7,38.7,,,33.5,44.2,Overall,Overall,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,26.3,26.3,,,20.4,33.3,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.3,28.3,,,21.0,37.1,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.2,30.2,,,21.7,40.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,22.0,22.0,,,14.2,32.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,24.7,24.7,,,19.0,31.5,Overall,Overall,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.5,29.5,,,21.9,38.3,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,20.6,20.6,,,12.5,32.2,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,18.7,18.7,,,10.9,30.2,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.6,33.6,,,24.9,43.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,23.4,23.4,,,15.2,34.3,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.4,40.4,,,34.4,46.8,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.9,41.9,,,34.4,49.8,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.9,39.9,,,33.0,47.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.6,40.6,,,33.2,48.5,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.8,39.8,,,33.9,46.1,Overall,Overall,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.4,40.4,,,33.7,47.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.5,37.5,,,27.9,48.3,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.5,37.5,,,27.8,48.3,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.7,45.7,,,35.9,55.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.7,42.7,,,34.0,52.0,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.5,27.5,,,17.5,40.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.5,40.5,,,33.2,48.3,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.1,32.1,,,21.4,45.1,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.4,34.4,,,22.7,48.3,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.6,40.6,,,31.5,50.3,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.2,41.2,,,32.0,51.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.4,38.4,,,31.2,46.2,Overall,Overall,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.5,49.5,,,39.1,59.9,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.0,45.0,,,37.4,52.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.4,39.4,,,28.9,50.9,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.8,45.8,,,38.7,53.1,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.9,44.9,,,37.2,52.7,Overall,Overall,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.3,39.3,,,28.5,51.3,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.4,48.4,,,39.3,57.6,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.0,39.0,,,34.2,44.1,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.3,37.3,,,30.6,44.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,18.6,18.6,,,12.1,27.5,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.1,43.1,,,37.0,49.6,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,21.9,21.9,,,14.2,32.3,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.1,34.1,,,27.4,41.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.4,38.4,,,33.3,43.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.6,39.6,,,34.7,44.8,Overall,Overall,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.1,44.1,,,38.0,50.4,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.4,33.4,,,26.9,40.6,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.4,31.4,,,23.8,40.2,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.4,40.4,,,32.3,49.1,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.2,44.2,,,35.9,52.8,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.3,36.3,,,30.0,43.2,Overall,Overall,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.4,39.4,,,34.1,45.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.5,30.5,,,20.8,42.4,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.9,32.9,,,25.9,40.8,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.7,31.7,,,21.8,43.5,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.2,31.2,,,20.8,43.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.6,31.6,,,25.2,38.8,Overall,Overall,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.7,30.7,,,19.5,44.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.0,32.0,,,22.4,43.4,Race/Ethnicity,Hispanic,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.4,32.4,,,24.7,41.1,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.4,29.4,,,20.5,40.4,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.5,30.5,,,21.3,41.6,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.3,33.3,,,21.3,47.8,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.8,40.8,,,31.5,50.7,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.7,45.7,,,38.0,53.7,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.4,42.4,,,36.1,48.9,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.2,44.2,,,34.4,54.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.7,39.7,,,31.3,48.8,Race/Ethnicity,Hispanic,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.1,46.1,,,38.3,54.0,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.8,42.8,,,36.4,49.4,Overall,Overall,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.9,44.9,,,32.9,57.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.4,35.4,,,25.6,46.5,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,25.3,48.0,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.8,30.8,,,19.4,45.1,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.9,34.9,,,22.3,50.0,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.8,32.8,,,23.1,44.2,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,20.4,54.9,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.8,29.8,,,18.8,43.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.4,32.4,,,20.1,47.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.2,31.2,,,21.7,42.7,Overall,Overall,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.1,25.1,,,16.4,36.6,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.8,32.8,,,26.0,40.3,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,30.5,37.0,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.6,29.6,,,22.0,38.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.8,30.8,,,19.8,44.6,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.1,38.1,,,24.3,54.2,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.8,31.8,,,28.0,35.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.6,49.6,,,31.3,68.1,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.1,26.1,,,21.5,31.4,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.0,31.0,,,23.1,40.2,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,29.8,37.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.1,27.1,,,22.0,33.0,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,26.1,40.7,Race/Ethnicity,Hispanic,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.3,32.3,,,29.2,35.6,Overall,Overall,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.4,36.4,,,32.3,40.7,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.6,37.6,,,33.1,42.4,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.0,39.0,,,34.0,44.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.2,37.2,,,32.1,42.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.4,34.4,,,26.7,42.9,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.8,33.8,,,26.6,41.8,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.1,50.1,,,36.2,64.0,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.4,39.4,,,34.9,44.1,Overall,Overall,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.7,39.7,,,34.2,45.3,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.7,41.7,,,36.3,47.4,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.1,47.1,,,32.3,62.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.0,30.0,,,21.8,39.8,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.7,32.7,,,23.2,43.9,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.8,35.8,,,28.4,43.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.4,31.4,,,26.0,37.2,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.9,34.9,,,27.7,42.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.0,32.0,,,25.4,39.3,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.6,32.6,,,27.0,38.9,Overall,Overall,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.6,32.6,,,25.9,40.2,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.1,42.1,,,35.6,48.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.9,46.9,,,39.7,54.2,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.7,42.7,,,37.0,48.6,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.2,28.2,,,21.0,36.7,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.5,41.5,,,35.7,47.5,Overall,Overall,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.8,39.8,,,33.4,46.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.3,31.3,,,23.0,40.9,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.0,37.0,,,31.3,43.1,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.9,38.9,,,31.8,46.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.7,35.7,,,27.1,45.4,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.6,38.6,,,31.3,46.5,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.6,26.6,,,17.0,39.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.2,40.2,,,32.7,48.1,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.3,30.3,,,19.6,43.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.5,38.5,,,32.7,44.6,Overall,Overall,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.7,35.7,,,29.3,42.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.2,34.2,,,26.2,43.2,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,17.7,17.7,,,13.4,23.1,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,21.3,21.3,,,15.5,28.5,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,17.5,17.5,,,13.2,22.8,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,19.6,19.6,,,14.8,25.5,Overall,Overall,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,19.2,19.2,,,14.4,25.2,Race/Ethnicity,Hispanic,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,18.3,18.3,,,13.3,24.5,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.5,36.5,,,25.9,48.7,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.5,33.5,,,26.9,40.8,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.2,32.2,,,26.0,39.0,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.3,35.3,,,28.5,42.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.4,36.4,,,27.1,46.9,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,28.7,43.7,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,27.4,39.2,Overall,Overall,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.6,31.6,,,23.9,40.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.1,32.1,,,21.1,45.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,27.2,41.0,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.9,39.9,,,32.6,47.7,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.8,34.8,,,28.9,41.3,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,19.6,19.6,,,13.2,28.1,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.8,36.8,,,25.2,50.1,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.0,39.0,,,30.7,47.9,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.8,30.8,,,24.6,37.7,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.3,33.3,,,27.7,39.4,Overall,Overall,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,20.1,20.1,,,13.3,29.2,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.4,42.4,,,31.1,54.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.8,40.8,,,21.5,63.5,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.3,30.3,,,15.8,50.2,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.4,41.4,,,30.5,53.2,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.1,45.1,,,32.0,58.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.1,30.1,,,17.9,45.9,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.7,37.7,,,23.7,54.1,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.3,40.3,,,28.6,53.1,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.6,41.6,,,29.3,55.1,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.6,38.6,,,29.0,49.2,Overall,Overall,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.2,37.2,,,29.5,45.5,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.1,37.1,,,30.3,44.5,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.2,48.2,,,34.2,62.5,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.6,43.6,,,35.9,51.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.6,49.6,,,35.9,63.4,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,29.7,44.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.3,41.3,,,34.2,48.7,Overall,Overall,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.5,32.5,,,26.0,39.7,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.1,31.1,,,24.9,38.1,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.0,27.0,,,15.2,43.4,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.5,40.5,,,31.7,49.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.8,29.8,,,24.6,35.6,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.2,37.2,,,29.2,45.9,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,26.1,26.1,,,14.7,42.1,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.8,34.8,,,28.4,41.8,Overall,Overall,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.8,25.8,,,16.2,38.4,Race/Ethnicity,Hispanic,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.4,26.4,,,18.0,36.8,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.8,27.8,,,15.6,44.7,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.4,34.4,,,26.3,43.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.4,29.4,,,19.9,41.2,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.4,38.4,**,US estimate/number is based on fewer than 50 states and the District of Columbia,35.7,39.7,Gender,Female,,,,,,,59,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.9,43.9,,,37.7,50.3,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.0,36.0,,,31.6,40.6,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.0,35.0,**,US estimate/number is based on fewer than 50 states and the District of Columbia,32.9,37.8,Overall,Overall,,,,,,,59,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.1,40.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,37.6,42.5,Gender,Female,,,,,,,59,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,23.7,23.7,,,18.1,30.3,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.1,37.1,,,32.2,42.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.0,37.0,**,US estimate/number is based on fewer than 50 states and the District of Columbia,34.8,39.9,Overall,Overall,,,,,,,59,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,21.2,49.0,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,23.5,23.5,,,17.7,30.4,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.9,36.9,,,31.9,42.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.6,34.6,,,22.3,49.4,Race/Ethnicity,Hispanic,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.1,32.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,30.5,34.1,Gender,Male,,,,,,,59,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.0,44.0,,,38.1,50.2,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.7,35.7,,,31.2,40.6,Overall,Overall,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.7,32.7,**,US estimate/number is based on fewer than 50 states and the District of Columbia,30.6,35.9,Gender,Male,,,,,,,59,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.1,34.1,,,25.5,43.8,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.3,44.3,,,37.8,50.9,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.5,39.5,,,34.2,45.2,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.8,42.8,,,36.1,49.8,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.0,32.0,,,22.2,43.6,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.5,43.5,,,37.2,50.0,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.6,38.6,,,27.9,50.5,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.5,33.5,,,25.0,43.2,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.5,40.5,,,35.3,45.9,Overall,Overall,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.2,43.2,,,36.6,50.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.4,35.4,,,21.7,52.0,Overall,Overall,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.4,36.4,,,29.7,43.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.6,37.6,,,27.8,48.5,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.9,40.9,,,34.2,47.9,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.4,41.4,,,33.2,50.1,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.8,36.8,,,29.1,45.2,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.8,39.8,,,28.9,51.7,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.7,37.7,,,31.1,44.9,Overall,Overall,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.0,40.0,,,33.2,47.3,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.4,44.4,,,39.0,50.1,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.5,41.5,,,36.9,46.3,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.5,31.5,,,21.0,44.4,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.7,44.7,,,38.8,50.8,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.0,42.0,,,37.7,46.5,Overall,Overall,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.6,36.6,,,23.7,51.9,Race/Ethnicity,Hispanic,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.9,43.9,,,38.9,49.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,24.6,50.6,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,29.7,44.1,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.1,42.1,,,36.7,47.6,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.5,33.5,,,19.7,50.9,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.3,37.3,,,30.4,44.7,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.6,32.6,,,22.5,44.7,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.6,47.6,,,39.4,56.0,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,56.0,56.0,,,47.1,64.5,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.8,55.8,,,46.7,64.6,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.4,48.4,,,40.9,56.0,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.0,50.0,,,43.0,57.1,Overall,Overall,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.5,49.5,,,41.9,57.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.1,38.1,,,27.9,49.4,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.8,35.8,,,30.9,41.0,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.9,44.9,,,38.7,51.4,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.6,40.6,,,35.5,45.9,Overall,Overall,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.9,37.9,,,31.8,44.4,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.3,32.3,,,24.4,41.3,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.7,35.7,,,30.5,41.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,25.1,42.1,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.4,40.4,,,35.0,46.1,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.7,37.7,,,29.3,46.9,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,OVERALL,OVR,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.7,33.7,,,25.2,43.4,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.6,30.6,,,19.4,44.7,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Multiracial, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,RACE,MRC,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,Hispanic,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,RACE,HIS,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.5,33.5,,,25.1,43.2,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.4,31.4,,,19.2,46.8,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.4,27.4,,,20.5,35.5,Race/Ethnicity,"White, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,RACE,WHT,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.5,42.5,,,31.3,54.6,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Black, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,RACE,BLK,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Race/Ethnicity,"Other, non-Hispanic",,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,RACE,OTH,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.8,32.8,,,25.2,41.3,Overall,Overall,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,OVERALL,OVR,,,,
